Thank You for an Amazing 2016 National Patient Education Conference!
From the Foundation's National Office, we’d like to thank everyone who
attended this year’s National Patient Education Conference in New Orleans for such an amazing weekend. The Conference provided an incredible
opportunity for the more than 630 registered guests to learn more about
scleroderma, and connect with others who are affected by the disease.
We are excited to announce the location for the 2017 Conference. We will be heading to The Grand Canyon State, Arizona! For more information on the Sheraton Grand at Wild Horse Pass, click here.
Sunburn prevention is very important during the summer, but it's also
crucial to practice good skincare even on cool, cloudy or hazy days.
This list from the Mayo Clinic offers a number of effective methods for
preventing sun damage to your skin, from sunscreen tips to times when
you should avoid sun exposure.
La Jolla Institute for Allergy and Immunology (LJI) Study Could Provide Important Target for Autoimmune Disease Interventions
Follicular helper T cells (Tfh cells), a rare type of T cells, are indispensable for the maturation of antibody-producing B cells. They promote the proliferation of B cells that produce highly selective antibodies against invading pathogens while weeding out those that generate potentially harmful ones. In their latest study, researchers at La Jolla Institute for Allergy and Immunology (LJI) identified a key signal that drives the commitment of immature Tfh cells into fully functional Tfh cells and thus driving the step-by-step process that results in a precisely tailored and effective immune response.
What the Science Really Says About GMOs and Food Safety
The United States has a new federal law that will, for the first time, require labeling of genetically modified ingredients in food. President Barack Obama signed the bill into law on Friday, July 31 and the secretary of agriculture has two years to finalize the labeling standard.
Disclaimer: The Scleroderma Foundation in no way
endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is
provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.
The Scleroderma Foundation is a qualified national nonprofit operating under 501(c)(3) status. The foundation’s federal tax identification number is 52-1375827. Our primary goal is to raise funds for our three-fold mission of support, education and research. The foundation has 20 active chapters and 160 support groups across the country.